Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: Richard Lowenthal
ARS Responds to FDA’s Request for Additional Study Before Approving neffy...
Dave Bloom
-
2023/09/20
FDA Issues Complete Response Letter for neffy® New Drug Application with Request for Additional Study.
FDA Delays Approval of neffy™ Intranasal Epinephrine Until September
Dave Bloom
-
2023/06/20
The expected approval date has been delayed from mid-year.
FDA Panel Supports Approval of neffy® Epinephrine Nasal Spray
Dave Bloom
-
2023/05/12
The first needle-free emergency epinephrine alternative is on the verge of FDA approval.
FDA Schedules Review of neffy®, an Intranasal Alternative to Epinephrine Auto-Injectors
Dave Bloom
-
2023/03/28
Meeting signals the FDA believes neffy has potential for approval given data gleaned from clinical trials.
FDA Accepts New Drug Application for Nasal Epinephrine Spray Treatment for...
Dave Bloom
-
2022/10/21
If approved, acceptance targeted for mid-2023.
CEO Expects Approval and Launch of Intranasal Emergency Epinephrine Spray by...
Dave Bloom
-
2022/03/02
The market for epinephrine delivery may expand to include non-needle alternatives next year.
Emergency Epinephrine Nasal Spray Takes Final Step Toward Approval in EU
Dave Bloom
-
2020/11/30
A needle-free option for administration of epinephrine is on the horizon.
ARS Pharmaceuticals Announces New Patent on ARS-1 (Epinephrine Nasal Spray)
News Wire ~ 3rd Party Press Release
-
2020/07/13
Intranasal delivery of emergency epinephrine takes another step closer to becoming a reality.
ARS to Present Data from Intranasal Epinephrine (ARS-1) Studies at AAAAI...
News Wire ~ 3rd Party Press Release
-
2020/03/02
Neffy™ (formally ARS-1) was fast-tracked by the FDA in 2019 as an intranasal alternative to epinephrine auto-injectors.
FDA Fast Tracks ARS-1 Intranasal Epinephrine Spray
News Wire ~ 3rd Party Press Release
-
2019/02/19
Company provides a novel means of administering emergency epinephrine.